| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68d5120969ae9dc39d88b07663480d6a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-43547 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-43559 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 |
| filingDate |
2019-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8bbea8028d41b61c988aa04ee1da114
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_727ee99a77500a5ffb649e9362590e5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9838b86f66ed378f0287274812075db2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d25afcb3b06703008e3f042345f44bfa |
| publicationDate |
2019-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-110627910-A |
| titleOfInvention |
Schistosoma mansoni recombinant fusion protein SmSAP and application thereof in schistosomiasis immune diagnosis |
| abstract |
The invention discloses a Schistosoma mansoni recombinant fusion protein SmSAP and application thereof in schistosomiasis immune diagnosis. The Schistosoma mansoni recombinant fusion protein SmSAP of the invention can be produced in large-scale standardized batch by a genetic engineering technology, and has stable antigen quality and good result repeatability. The Schistosoma mansoni recombinant fusion protein SmSAP of the invention can be used for immune diagnosis of Schistosoma mansoni and immune diagnosis of Schistosoma Egypti, and has extremely high sensitivity. The Schistosoma mansoni recombinant fusion protein SmSAP has single antigen component, and the SmSAP-ELISA has excellent specificity on schistosomiasis immune diagnosis, does not have cross reaction with serum of other parasitic disease patients, and has wide application prospect. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112779276-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112779277-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112779276-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112779277-A |
| priorityDate |
2019-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |